New inhaled drug shows promise for cystic fibrosis in early trial
NCT ID NCT06478706
First seen Jan 05, 2026 · Last updated May 16, 2026 · Updated 20 times
Summary
This study tested a new inhaled medicine called ETD001 in 57 adults with cystic fibrosis. The goal was to see if it is safe and if it can improve lung function. Participants took the drug twice a day for up to 28 days and had their breathing tested. The results will help decide if larger studies are needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
All Wales Adult CF Centre
Cardiff, CF64 2XX, United Kingdom
-
Azienda Ospedaliera Universitaria Integrata Verona
Verona, 37126, Italy
-
Azienda Ospedaliera Universitaria Meyer
Florence, 50139, Italy
-
Belfast Health and Social Care Trust
Belfast, BT9 7AB, United Kingdom
-
CF-Studienzentrum Universitätsklinikum Köln
Cologne, 50924, Germany
-
CHU de Montpellier
Montpellier, 34295, France
-
Charité Universtaetsmedizin
Berlin, 13353, Germany
-
Fondazione IRCCS Ca' Granda- Ospedale Maggiore Policlinico
Milan, 20122, Italy
-
Hospices Civils de Lyon
Lyon, 69495, France
-
Hôpital Cochin
Paris, 75014, France
-
Hôpitaux de Toulouse
Toulouse, 31059, France
-
IKF Pneumologie
Frankfurt, 60596, Germany
-
IRCCS Istituto Giannina Gaslini
Genova, 16147, Italy
-
LMU Kinikum
Munich, 80336, Germany
-
Ospedale Pediatrico Bambino Gesù
Roma, 00165, Italy
-
Queen Elizabeth University Hospital West of Scotland CF Service
Glasgow, G51 4TR, United Kingdom
-
Royal Brompton Hospital
London, SW3 6LL, United Kingdom
-
Royal Papworth Hospital
Cambridge, CB2 0AY, United Kingdom
-
Southampton General Hospital
Southampton, SO16 6YD, United Kingdom
-
Universitätsklinikum Frankfurt
Frankfurt, 60590, Germany
-
Westdeutsches Lungenzentrum am Universitätsklinikum
Essen, 45239, Germany
Conditions
Explore the condition pages connected to this study.